Ben Bowman, Co-Founder & CEO
Ben Bowman is one of the few experts on the national market for blood components. After 5 years compiling and analyzing pricing and production trends, Mr. Bowman co-founded General Blood to ensure availability and competitive pricing for hospitals across the United States. Mr. Bowman also has an extensive background in manufacturing, spending the earlier part of his career in metal component manufacturing. One of his most notable achievements was starting a 65,000 sq feet state-of-the-art manufacturing facility in Torreón, Mexico. By combining best practices in inventory management and the knowledge of the blood market, Mr. Bowman is uniquely positioned to drive efficiency, availability and cost savings in the blood market.
Mr. Bowman received both his undergraduate degree and MBA from the University of Minnesota’s Carlson School of Management. He lives in Saint Paul, Minnesota with his wife and three young children.
Dave Mitchell, Co-Founder & EVP
Dave Mitchell has immersed himself in the blood industry over the last two years to understand the entire supply chain of blood from the arm to arm. Mr. Mitchell has built the first of its kind network of high performing blood banks around the country that are eager to increase collections and help those in need.
Mr. Mitchell has extensive background in sales, financial analysis, and marketing. David began his career in financial services and consulting. His diverse background has provided a unique and fresh perspective on solving supply chain problems in the blood industry. Through aggregating information on donor trends and supply shortfalls around the country, Mr. Mitchell ensures blood can move to where it is needed most.
Mr. Mitchell received undergraduate degrees in History and Economics from Colby College in Waterville, Maine; and an MBA from Minnesota’s Carlson School of Management. He lives in Minneapolis, Minnesota with his wife.
Dr. Jerry Holmberg, Board Member
Dr. Jerry Holmberg is the Director, Scientific Affairs at Novartis Vaccines and Diagnostics, where he oversees global scientific affairs. Novartis Vaccines and Diagnostics’ core business is blood safety through nucleic acid testing and blood group genomics. He has more than 30 years in all areas of laboratory medicine with a concentration on blood bank operations, education, and policy.
Dr. Holmberg served twenty years in the US Navy, achieving the rank of Commander. During his military career he held various positions directing blood banks, blood donor centers, frozen blood bank depots, blood bank computer systems and policy development within the Navy Blood Program. His military career included two tours of duty at the National Naval Medical Center, US Pacific Command Joint Blood Program Office in Okinawa, Japan, Functional Program Manger for the Defense Blood Standard System, Head of Navy Blood Program, and Laboratory Chief of the Blood Bank Branch of the Joint Readiness Clinical Advisory Board. Upon leaving the military Dr. Holmberg held positions at Haemonetics Corporation involving medical devices for blood collection and cell processing of frozen blood within a closed system for extended storage.
For over eight years, Dr. Holmberg served the US again in public health at the Federal level. He served under two political administrations as the Senior Advisor for Blood Policy and the Executive Secretary for the Advisory Committee on Blood Safety and Availability for the U. S. Secretary of the Department of Health and Human Service (HHS). As a public servant, he served three Secretaries of HHS and three Assistant Secretaries for Health as their Senior Advisor for Blood Policy. During his tenure, he led the Department in a review of men who have had sex with other men (MSM) policy, pathogen reduction technology, Hepatitis Action Plan, Biovigilance, blood inventory management and disaster planning.
His concern and dedication to serve the underserved has motivated him to actively participate in the President’s Emergency Plan for AIDS Relief (PEPFAR). Eliminating the risk of transfusion transmitted diseases, especially HIV, in the blood supply has been a personal goal. Over the last five years, he has traveled to many developing countries in Africa, South America and Central Asia Republics to provide technical assistance in blood safety and availability.
In 2009, Dr. Holmberg received the AABB President’s award for his activities in Biovigilance. He is a leader in both national and international biovigilance activities.
Dr. Holmberg received his B.S. in Biology from Saginaw Valley State College, his Medical Technology training at St. Luke’s Hospital in Saginaw, Michigan and M.S. in the Department of Pathology, Clinical Laboratory Science from Michigan State University. He completed a Fellowship in Blood Bank at Walter Reed Army Medical Center which led to certification as a blood bank specialist. Following his Fellowship, he obtained a Ph.D. in Biological Sciences from Bowling Green State University with an emphasis on immunohematolgy. He holds certifications in medical technology, specialist in blood bank technology, and quality assurance.